Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Forum of Clinical Oncology
Volume 11 (2020): Issue 1 (March 2020)
Open Access
Clinical biomarkers directing the management of patients with colon and lung cancer (beyond oncogene-addicted NSCLC)
Ioannis Ntanasis-Stathopoulos
Ioannis Ntanasis-Stathopoulos
,
Anastasios Kyriazoglou
Anastasios Kyriazoglou
,
Meletios A. Dimopoulos
Meletios A. Dimopoulos
and
Maria Gavriatopoulou
Maria Gavriatopoulou
| Sep 08, 2020
Forum of Clinical Oncology
Volume 11 (2020): Issue 1 (March 2020)
About this article
Previous Article
Next Article
Abstract
Article
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Research Article
Published Online:
Sep 08, 2020
Page range:
3 - 6
Received:
Aug 26, 2019
Accepted:
Nov 05, 2019
DOI:
https://doi.org/10.2478/fco-2019-0014
Keywords
biomarker
,
therapeutics
,
cancer
,
PD-L1
,
KRAS
© 2020 Ioannis Ntanasis-Stathopoulos et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.